Denise Mueller
Corporate Officer/Principal at AFFIMED N.V.
Net worth: 438 595 $ as of 2024-04-29
Network origin in Denise Mueller first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
26
| Public Company | Biotechnology | 26 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Denise Mueller via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
Affimed GmbH
 Affimed GmbH Miscellaneous Commercial ServicesCommercial Services Part of Affimed NV, Affimed GmbH is a clinical leader in innate immuno-oncology. The company, based in Heidelberg, Germany, develops proprietary cancer-targeting bispecific antibodies that activate the innate immune system to kill tumor cells. Affimed leads clinical development of innate cell engagers for solid/hematologic tumors as monotherapy, in combination with NK cells or with checkpoint inhibitors. Adolf Hoess has been the CEO of the German company since 2010. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Chairman Director/Board Member Director/Board Member Chief Executive Officer Director/Board Member Director/Board Member Director/Board Member Chief Operating Officer | |
| Ludwig-Maximilians-Universität München | College/University | Doctorate Degree Undergraduate Degree Graduate Degree | |
| MORPHOSYS AG | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal Public Communications Contact | |
| University of Freiburg | College/University | Doctorate Degree Doctorate Degree Graduate Degree | |
Shire Orphan Therapies GmbH
 Shire Orphan Therapies GmbH Pharmaceuticals: MajorHealth Technology Shire Orphan Therapies GmbH engages in the development, manufacture, and distribution of chemical and biochemical products, ingredients, as well as pharmaceutical and diagnostic products. The company was founded in 1994 and is headquartered in Berlin, Germany. | Pharmaceuticals: Major | Director of Finance/CFO Corporate Officer/Principal | |
Affimed NV Niederlassung Deutschland
 Affimed NV Niederlassung Deutschland Pharmaceuticals: MajorHealth Technology Affimed NV Niederlassung Deutschland discovers and develops antibody-based therapeutic drugs. The firm generates and develops a pipeline of antibody product candidates based on proprietary technology platform. It offer therapeutic drugs that target autoimmune diseases and tumor cells. The company was founded in 2000 and is headquartered in Heidelberg, Germany. | Pharmaceuticals: Major | Corporate Officer/Principal Chief Executive Officer | |
Kuur Therapeutics Ltd.
 Kuur Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Kuur Therapeutics provides clinical cellular therapeutics services. It develops, manufactures and markets personalized cellular immunotherapeutics for infectious disease and cancer. Cell Medica has developed proprietary production technology enabling GMP compliant manufacture of antigen-specific T cells. The company was founded by Gregg Sando in 2006 and is headquartered in London, the United Kingdom. | Pharmaceuticals: Major | Chairman Chairman | |
| Technische Universität München | College/University | Doctorate Degree Doctorate Degree | |
Vaximm AG
 Vaximm AG Miscellaneous Commercial ServicesCommercial Services Vaximm AG provides active immunotherapies for patients suffering from cancer. It develops and provides vaccines for patients suffering from cancer. The firmalso provides research, development, manufacture, marketing and sale of pharmaceutical products. The company was founded in September 2008 and is headquartered in Basel, Switzerland. | Miscellaneous Commercial Services | Chairman Director/Board Member | |
| University of Pennsylvania | College/University | Undergraduate Degree Graduate Degree | |
| BIOTEST AG | Pharmaceuticals: Other | Chairman Director/Board Member | |
| MERCK KGAA | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Amphivena Therapeutics, Inc.
 Amphivena Therapeutics, Inc. Drugstore ChainsRetail Trade Amphivena Therapeutics, Inc. provides drug discovery services. It develops tetravalent, T-cell redirecting bispecific antibodies for the treatment of hematologic malignancies. The firm’s’ lead drug candidate is AMV-564, a CD33/CD3-targeting treatment for acute myeloid leukemia (AML), which Amphivena is currently preparing to advance into clinical development. The company was founded by Jeanmarie Guenot in December 2012 and is headquartered in San Francisco, CA. | Drugstore Chains | Director/Board Member Director/Board Member | |
| ONCIMMUNE HOLDINGS PLC | Biotechnology | Director/Board Member | |
| ENZON PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| SILENCE THERAPEUTICS PLC | Miscellaneous Commercial Services | Chief Executive Officer | |
Vium, Inc.
 Vium, Inc. Information Technology ServicesTechnology Services Vium, Inc. provides technology for preclinical drug discovery services. It offers biomedical investigators with technology that accelerates the preclinical drug discovery and development pipeline. The company was founded by Timothy L. Robertson and Jonathan Betts-Lacroix in 2013 and is headquartered in San Mateo, CA. | Information Technology Services | Chairman | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
iOX Therapeutics Ltd.
 iOX Therapeutics Ltd. BiotechnologyHealth Technology iOX Therapeutics Ltd. provides cancer therapeutics services. The company was founded by Vincenzo Cerundolo in February 2015 and is headquartered in London, the United Kingdom. | Biotechnology | Director/Board Member | |
Coqual
 Coqual Miscellaneous Commercial ServicesCommercial Services Coqual, formerly known as the Center for Talent Innovation, is a nonprofit think tank that helps leaders create diverse, equitable, and inclusive workplaces. The non-profit company is based in New York, NY, and was founded by Sylvia Ann Hewlett. The company focuses on conducting cutting-edge research and providing advisory services on various identities, including gender, race, ethnicity, disability, veteran status, and LGBTQ. Coqual was founded in 2004 and offers in-depth research, thought leadership, and data-driven solutions to address bias and barriers to inclusion for underrepresented populations in the workplace. Lanaya Irvin has been the CEO of the company since 2020. | Miscellaneous Commercial Services | Director/Board Member | |
| ONCOSEC MEDICAL INCORPORATED | Medical/Nursing Services | Director/Board Member | |
Cocoon Biotech, Inc.
 Cocoon Biotech, Inc. BiotechnologyHealth Technology Cocoon Biotech, Inc. develops and manufactures medicines for osteoarthritis patients. The company was founded by Ailis Tweed-Kent in 2013 and is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member | |
| MedCity Ltd. | Director/Board Member | ||
Thrombolytic Science International LLC
 Thrombolytic Science International LLC Pharmaceuticals: MajorHealth Technology Thrombolytic Science International LLC operates as a vascular medicine and biotech company. The company was founded by Alexis Wallace and Victor Gurewich and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Director/Board Member | |
PhESi LLC
 PhESi LLC Pharmaceuticals: MajorHealth Technology PhESi LLC provides drug and clinical development services for life sciences companies. The private company is based in East Lyme. | Pharmaceuticals: Major | Director/Board Member | |
| AVROBIO, INC. | Biotechnology | Director/Board Member | |
AOBiome Therapeutics, Inc.
 AOBiome Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology AOBiome Therapeutics, Inc. develops microbiome-targeted therapies for local, nasal and systemic inflammatory conditions. Its portfolio includes three clinical-stage programs, a Phase 2b study to treat patients with acne vulgaris, a Phase 2 trial to reduce elevated blood pressure, and a Phase 1b/2a clinical trial in allergic rhinitis, as well as earlier-stage preclinical programs targeting diverse inflammatory indications. The company was founded by Jamie Heywood, David Whitlock and Lenny Barshack in 2013 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Director/Board Member | |
| SENSYNE HEALTH PLC | Miscellaneous Commercial Services | Chairman | |
| COMPASS PATHWAYS PLC | Biotechnology | Director/Board Member | |
| London School of Hygiene & Tropical Medicine | College/University | Corporate Officer/Principal | |
| The European Commission | General Government | Corporate Officer/Principal | |
Oncimmune Ltd.
 Oncimmune Ltd. BiotechnologyHealth Technology Oncimmune Ltd. provides clinical testing services for cancer detection. The firm develops early cancer detection tests for lung, breast, colorectal, prostate, stomach, pancreatic and ovarian cancers. The company was founded by John F. R. Robertson in 2003 and is headquartered in Nottingham, the United Kingdom. | Biotechnology | Director/Board Member | |
PlaqueTec Ltd.
 PlaqueTec Ltd. Miscellaneous Commercial ServicesCommercial Services PlaqueTec Ltd. develops a liquid biopsy system platform technology that provides unparalleled resolution of the biological processes that cause coronary artery disease. The firm’s Liquid Biopsy System addresses the underlying biomarker collection problems preventing advances in CAD research. The company was founded by Stephen Blatcher in 2000 and is headquartered in Cambridge, the United Kingdom. | Miscellaneous Commercial Services | Chief Executive Officer | |
COMPASS Pathfinder Holdings Ltd.
 COMPASS Pathfinder Holdings Ltd. Financial ConglomeratesFinance Part of Compass Pathways Plc, COMPASS Pathfinder Holdings Ltd. is an investment holding British company. The company is based in London, UK and was founded in 2017. | Financial Conglomerates | Director/Board Member | |
Women in Bio, Inc.
 Women in Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Women in Bio, Inc. is an organization that supports women in the life sciences industry. The non-profit company is based in Bethesda, MD and has subsidiaries in the United States. The organization has 13 chapters in the United States and is funded by sponsors and partners who are dedicated to supporting diversity and inclusion for women of all ages. Founded in 2002, it offers professional educational programs, peer-to-peer learning, mentoring, and networking opportunities for women at all career levels. Women in Bio was founded by Faith L. Charles and Cynthia Wong Hu. | Miscellaneous Commercial Services | Director/Board Member | |
Women's Forum, Inc.
 Women's Forum, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Leadership Foundations, Women's Forum, Inc. is a non-profit community for women leaders of diverse achievement. The company is based in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Biothera Pharmaceutical, Inc.
 Biothera Pharmaceutical, Inc. Medical/Nursing ServicesHealth Services Biothera Pharmaceutical, Inc. operates as a biotechnology company. It develops Imprime PGG, a novel dectin receptor agonist that reverses tumor-mediated immunosuppression while promoting antigen presentation to drive T cell activation. The company was founded in 1997 and is headquartered in Roseville, MN. | Medical/Nursing Services | Director/Board Member | |
| KARO PHARMA AB (PUBL) | Pharmaceuticals: Major | Director/Board Member | |
Maxion Therapeutics Ltd.
 Maxion Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Maxion Therapeutics is a British company that specializes in creating first-in-class and protein therapeutics for treating previously untreatable ion channel- and GPCR-driven diseases. The company was founded by John McCafferty, Aneesh Karatt-Vellatt, and is based in London, UK. The company achieves this through their revolutionary KnotBody® technology. John McCafferty has been the CEO since incorporation. | Pharmaceuticals: Major | Chief Executive Officer | |
ImClone LLC
 ImClone LLC BiotechnologyHealth Technology ImClone LLC develops targeted biologic treatments designed for the medical needs of patients with tumors. The company was founded in 1984 and is headquartered in Bridgewater, NJ. | Biotechnology | Corporate Officer/Principal | |
| MOLECULAR PARTNERS AG | Biotechnology | Chief Tech/Sci/R&D Officer | |
| University of Hannover | College/University | Doctorate Degree | |
Merck Serono Ltd.
 Merck Serono Ltd. Miscellaneous Commercial ServicesCommercial Services Merck Serono Ltd. provides research and development services and manufactures medicinal drugs. The company is headquartered in Middlesex, the United Kingdom. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Lilly Oncology
 Lilly Oncology Hospital/Nursing ManagementHealth Services Part of Eli Lilly & Co., Lilly Oncology is an American company dedicated to delivering life-changing medicines and support to people living with cancer and those who care for them. With over 50 years of experience, Lilly Oncology is committed to building on their heritage and improving the lives of all those affected by cancer worldwide. | Hospital/Nursing Management | Director/Board Member | |
| University of Duisburg-Essen | College/University | Corporate Officer/Principal | |
Chemitra GmbH
 Chemitra GmbH Pharmaceuticals: MajorHealth Technology Chemitra GmbH is a private holding firm. Chemitra has interests in pharmaceutical manufacturing and chemical preparations. It was incorporated on the 28th of February, 1945 and is headquartered in Darmstadt, Germany. | Pharmaceuticals: Major | Chief Executive Officer | |
Allergopharma GmbH & Co. KG
 Allergopharma GmbH & Co. KG Pharmaceuticals: MajorHealth Technology Allergopharma GmbH & Co. KG manufactures pharmaceutical products. It offers Allergen-specific immunotherapy (SIT), also known as hyposensitization or desensitization, allergy vaccination. The firm provides products for the causal treatment of IgE-mediated allergic diseases. The company was founded by Joachim Ganzer and Hermal Ganzer in 1969 and is headquartered in Reinbek, Germany. | Pharmaceuticals: Major | Chief Executive Officer |
Statistics
International
| United States | 19 |
| Germany | 14 |
| United Kingdom | 14 |
| Switzerland | 4 |
| Netherlands | 2 |
Sectoral
| Health Technology | 26 |
| Commercial Services | 11 |
| Consumer Services | 8 |
| Health Services | 4 |
| Retail Trade | 2 |
Operational
| Director/Board Member | 134 |
| Corporate Officer/Principal | 46 |
| Chairman | 38 |
| Independent Dir/Board Member | 37 |
| Chief Executive Officer | 26 |
Most connected contacts
| Insiders | |
|---|---|
| Annalisa Jenkins | 51 |
| Ferdinand Verdonck | 25 |
| Thomas O. Hecht | 24 |
| Berndt A. E. Modig | 23 |
| Harry Welten | 22 |
| Mathieu Simon | 22 |
| Bernhard R. M. Ehmer | 16 |
| Uta Kemmerich-Keil | 16 |
| Ulrich Grau | 12 |
| Leila Alland | 11 |
| Adolf Hoess | 11 |
| Florian Fischer | 11 |
| Constanze Ulmer-Eilfort | 8 |
| Andreas Harstrick | 7 |
| Arndt Justus Georg Schottelius | 7 |
- Stock Market
- Insiders
- Denise Mueller
- Company connections
